Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

radiologist radiology pay compensation money dollar

New radiology research highlights inherent ‘unfairness’ in RVU system

Some CPT billing code descriptions leave ambiguity as to the number of image views involved in an exam, resulting in variability in interpretation times.  

Anthem

Q&A: Vulnerable patients hit hardest by anesthesia reimbursement cuts

Tracy Young, CRNA, vice president at the American Association of Nurse Anesthesiology, details the ongoing fight between providers and insurers over how anesthesiologists get paid. 

Recor Medical's Paradise Ultrasound Renal Denervation System

Momentum continues for renal denervation as CMS considers national Medicare coverage

CMS is accepting public comments on the topic for a period of 30 days. Recor Medical and Medtronic have both shared statements in support of the potential policy shift.

American College of Radiology ACR

ACR wants radiologist feedback as CDC eyes nonphysician X-ray reads

The agency is considering whether to let NPs and PAs examine radiographs in a federal health surveillance program. 

circuit board

Industry Watcher’s Digest

Having released the latest version of Llama in December, Meta is telling the world that open-source AI is the future of AI in healthcare. 

4 ways HHS plans to help shape a national strategy for healthcare AI

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.

johnson & johnson branding

Johnson & Johnson buys depression drug and its manufacturer for $15B

The drug Caplyta, owned by Intra-Cellular Therapies, is being used to treat bipolar disorder and schizophrenia. In 2024, it brought in more than $481 million in sales. 

the words "FDA recall" on a board

FDA announces recall after Philips heart monitor software failed to send alerts—multiple deaths reported

Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries.